Cargando…

Encephalartos villosus Lem. Displays a Strong In Vivo and In Vitro Antifungal Potential against Candida glabrata Clinical Isolates

Recently, Candida glabrata has been recognized as one of the most common fungal species that is highly associated with invasive candidiasis. Its spread could be attributed to its increasing resistance to antifungal drugs. Thus, there is a high need for safer and more efficient therapeutic alternativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alqahtani, Moneerah J., Elekhnawy, Engy, Negm, Walaa A., Mahgoub, Sebaey, Hussein, Ismail A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146621/ https://www.ncbi.nlm.nih.gov/pubmed/35628776 http://dx.doi.org/10.3390/jof8050521

Ejemplares similares

Plausible Protective Role of Encephalartos villosus Extract in Acetic-Acid-Induced Ulcerative Colitis in Rats
por: Alanazi, Ashwag S., et al.
Publicado: (2023)

Promising Antifungal Activity of Encephalartos laurentianus de Wild against Candida albicans Clinical Isolates: In Vitro and In Vivo Effects on Renal Cortex of Adult Albino Rats
por: Negm, Walaa A., et al.
Publicado: (2022)

Silver Nanoparticles Prepared Using Encephalartos laurentianus De Wild Leaf Extract Have Inhibitory Activity against Candida albicans Clinical Isolates
por: Alherz, Fatemah A., et al.
Publicado: (2022)

Anti-Biofilm and Antibacterial Activities of Cycas media R. Br Secondary Metabolites: In Silico, In Vitro, and In Vivo Approaches
por: Attallah, Nashwah G. M., et al.
Publicado: (2022)

The potential application of probiotics for the prevention and treatment of COVID-19
por: Elekhnawy, Engy, et al.
Publicado: (2022)

Bilosomes as Nanoplatform for Oral Delivery and Modulated In Vivo Antimicrobial Activity of Lycopene
por: Binsuwaidan, Reem, et al.
Publicado: (2022)

Foliicolous microfungi occurring on Encephalartos
por: Crous, P.W., et al.
Publicado: (2008)

Anti-inflammatory potential of Penicillium brefeldianum endophytic fungus supported with phytochemical profiling
por: Saleh, Asmaa, et al.
Publicado: (2023)

Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate
por: Mota, Sandra, et al.
Publicado: (2015)

Biguanides enhance antifungal activity against Candida glabrata
por: Xu, Shuying, et al.
Publicado: (2018)

Effect of Antifungal-Treated Host Macrophages on Candida glabrata
por: Li, Hong-Bin, et al.
Publicado: (2021)

Catechin potentiates the antifungal effect of miconazole in Candida glabrata
por: Hervay, Nora Tóth, et al.
Publicado: (2023)

Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates
por: Andersen, Kari-Mette, et al.
Publicado: (2016)

Roles of Elm1 in antifungal susceptibility and virulence in Candida glabrata
por: Ito, Yuya, et al.
Publicado: (2020)

Evaluation of antifungal susceptibility in clinical isolates of the Candida glabrata complex
por: Jesus, Filipa, et al.
Publicado: (2021)

Antifungal Resistance in Clinical Isolates of Candida glabrata in Ibero-America
por: Martínez-Herrera, Erick, et al.
Publicado: (2021)

The Mechanistic Perspective of Bilobetin Protective Effects against Cisplatin-Induced Testicular Toxicity: Role of Nrf-2/Keap-1 Signaling, Inflammation, and Apoptosis
por: Negm, Walaa A., et al.
Publicado: (2022)

In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis
por: Amirrajab, Nasrin, et al.
Publicado: (2023)

Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata
por: Tscherner, Michael, et al.
Publicado: (2011)

Multi-route antifungal administration in the management of urinary Candida glabrata bezoar
por: Viswambaram, Pravin, et al.
Publicado: (2020)

Investigation of the Antibacterial Activity and Efflux Pump Inhibitory Effect of Cycas thouarsii R.Br. Extract against Klebsiella pneumoniae Clinical Isolates
por: Negm, Walaa A., et al.
Publicado: (2021)

Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols
por: Elekhnawy, Engy, et al.
Publicado: (2022)

Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection
por: Pais, Pedro, et al.
Publicado: (2019)

Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing
por: Spettel, Kathrin, et al.
Publicado: (2019)

Microsatellite Typing and Antifungal Susceptibility of Candida glabrata Strains Isolated From Patients With Candida Vaginitis
por: Kiasat, Neda, et al.
Publicado: (2019)

The MNN2 Gene Knockout Modulates the Antifungal Resistance of Biofilms of Candida glabrata
por: Rodrigues, Célia F., et al.
Publicado: (2018)

Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata
por: Minematsu, Asuka, et al.
Publicado: (2019)

Evaluation of antifungal activity of mint, pomegranate and coriander on fluconazole-resistant Candida glabrata
por: Jayan, Lekshmy, et al.
Publicado: (2020)

Candida glabrata Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination
por: Frías-De-León, María Guadalupe, et al.
Publicado: (2021)

Exhibition of antifungal resistance by sterol-auxotrophic strains of Candida glabrata with intact virulence
por: Nagi, Minoru, et al.
Publicado: (2022)

In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST
por: Fatahinia, Mahnaz, et al.
Publicado: (2020)

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata
por: Gamal, Ahmed, et al.
Publicado: (2021)

Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species
por: Nagayoshi, Yohsuke, et al.
Publicado: (2017)

Tumours of the liver, kidney and lungs in rats fed Encephalartos hildebrandtii.
por: Mugera, G. M., et al.
Publicado: (1968)

Candida glabrata candidemia
por: Chakrabarti, Arunaloke
Publicado: (2015)

Adhesins in Candida glabrata
por: Timmermans, Bea, et al.
Publicado: (2018)

In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen
por: Amirrajab, Nasrin, et al.
Publicado: (2016)

Galleria mellonella as a host model to study Candida glabrata virulence and antifungal efficacy
por: Ames, Lauren, et al.
Publicado: (2017)

Antifungal Activity of a Hydroethanolic Extract From Astronium urundeuva Leaves Against Candida albicans and Candida glabrata
por: Bonifácio, Bruna Vidal, et al.
Publicado: (2019)

Genomic Assembly of Clinical Candida glabrata (Nakaseomyces glabrata) Isolates Reveals within-Species Structural Plasticity and Association with In Vitro Antifungal Susceptibility
por: Stefanini, Irene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j81rq24deohll4aq1irr4ek1ln